Physician profile
Subhan Mohammed
NPI 1760865869
$7,950.06
in general payments reported to CMS, 2019-2025
21 companies · $2,701 in 2025
The $2,701 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.84 · 2023: $235 · 2024: $4,997 · 2025: $2,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,195 · Food and Beverage: $2,058 · Travel and Lodging: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,194.61 |
| Food and Beverage | $2,057.61 |
| Travel and Lodging | $1,680.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,747.00 | 2024-2025 | |
| Genzyme Corporation | $655.25 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $429.29 | 2024-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $183.40 | 2023-2025 | Glassia |
| United Therapeutics Corporation | $173.32 | 2023-2025 | Tyvaso |
| Astrazeneca Pharmaceuticals Lp | $130.39 | 2023-2025 | Fasenra, Tezspire, Airsupra |
| Insmed, INC. | $111.94 | 2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $95.14 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $85.63 | 2024-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Pulmonx Corporation | $44.90 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Mylan Specialty L.P. | $33.43 | 2023-2024 | Yupelri |
| Amgen INC. | $31.51 | 2024-2025 | Tezspire |
| Verona Pharma, INC. | $25.99 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $22.92 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $22.83 | 2024 | |
| Boston Scientific Corporation | $17.84 | 2021 | |
| Viatris Specialty LLC | $16.96 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.85 | 2024 | Ofev |
| Baxter Healthcare | $15.46 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Itamar Medical INC | $11.02 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhan Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.